- Home
- CMP vs RZLT Comparison
CMP vs RZLT Comparison
Compare CMP & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMP
- RZLT
- Stock Information
- Founded
- CMP 1993
- RZLT 2010
- Country
- CMP United States
- RZLT United States
- Employees
- CMP N/A
- RZLT N/A
- Industry
- CMP Other Metals and Minerals
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- CMP Basic Materials
- RZLT Health Care
- Exchange
- CMP Nasdaq
- RZLT Nasdaq
- Market Cap
- CMP 781.2M
- RZLT 626.4M
- IPO Year
- CMP 2003
- RZLT N/A
- Fundamental
- Price
- CMP $19.05
- RZLT $7.12
- Analyst Decision
- CMP Hold
- RZLT Strong Buy
- Analyst Count
- CMP 3
- RZLT 5
- Target Price
- CMP $20.00
- RZLT $12.50
- AVG Volume (30 Days)
- CMP 433.6K
- RZLT 716.3K
- Earning Date
- CMP 08-11-2025
- RZLT 09-18-2025
- Dividend Yield
- CMP N/A
- RZLT N/A
- EPS Growth
- CMP N/A
- RZLT N/A
- EPS
- CMP N/A
- RZLT N/A
- Revenue
- CMP $1,225,200,000.00
- RZLT N/A
- Revenue This Year
- CMP $11.87
- RZLT N/A
- Revenue Next Year
- CMP $3.28
- RZLT N/A
- P/E Ratio
- CMP N/A
- RZLT N/A
- Revenue Growth
- CMP 7.27
- RZLT N/A
- 52 Week Low
- CMP $7.51
- RZLT $2.22
- 52 Week High
- CMP $22.69
- RZLT $7.46
- Technical
- Relative Strength Index (RSI)
- CMP 47.13
- RZLT 74.14
- Support Level
- CMP $18.89
- RZLT $6.23
- Resistance Level
- CMP $20.11
- RZLT $7.46
- Average True Range (ATR)
- CMP 0.83
- RZLT 0.32
- MACD
- CMP 0.03
- RZLT 0.03
- Stochastic Oscillator
- CMP 44.75
- RZLT 77.59
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.